Richard Lazzaro, MD, FACS, thoracic surgeon, RWJ Barnabas Health, discusses the advantages of standard low-dose computed tomography (CT) scans in lung cancer screening in high-risk individuals, as well as future opportunities to integrate biomarker-based assays into screening protocols to improve early detection. Watch more at onclive.com.